ACADIA Pharmaceuticals Inc (ACAD)
17.16
-0.04
(-0.23%)
USD |
NASDAQ |
Apr 18, 12:05
ACADIA Pharmaceuticals Shareholders Equity (Quarterly): 431.76M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 431.76M |
September 30, 2023 | 362.17M |
June 30, 2023 | 395.79M |
March 31, 2023 | 374.26M |
December 31, 2022 | 400.41M |
September 30, 2022 | 425.69M |
June 30, 2022 | 434.85M |
March 31, 2022 | 444.80M |
December 31, 2021 | 540.89M |
September 30, 2021 | 566.96M |
June 30, 2021 | 564.84M |
March 31, 2021 | 581.61M |
December 31, 2020 | 627.01M |
September 30, 2020 | 654.87M |
June 30, 2020 | 663.01M |
March 31, 2020 | 638.38M |
December 31, 2019 | 699.14M |
September 30, 2019 | 689.29M |
June 30, 2019 | 388.91M |
March 31, 2019 | 418.36M |
December 31, 2018 | 479.08M |
September 30, 2018 | 223.44M |
June 30, 2018 | 264.72M |
March 31, 2018 | 304.17M |
December 31, 2017 | 335.28M |
Date | Value |
---|---|
September 30, 2017 | 377.33M |
June 30, 2017 | 415.14M |
March 31, 2017 | 457.52M |
December 31, 2016 | 518.41M |
September 30, 2016 | 578.06M |
June 30, 2016 | 408.82M |
March 31, 2016 | 445.25M |
December 31, 2015 | 199.76M |
September 30, 2015 | 227.35M |
June 30, 2015 | 255.82M |
March 31, 2015 | 285.09M |
December 31, 2014 | 309.49M |
September 30, 2014 | 330.49M |
June 30, 2014 | 350.11M |
March 31, 2014 | 365.46M |
December 31, 2013 | 182.13M |
September 30, 2013 | 180.75M |
June 30, 2013 | 181.48M |
March 31, 2013 | 79.66M |
December 31, 2012 | 84.98M |
September 30, 2012 | 17.66M |
June 30, 2012 | 12.71M |
March 31, 2012 | 17.58M |
December 31, 2011 | 23.36M |
September 30, 2011 | 28.14M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
362.17M
Minimum
Sep 2023
699.14M
Maximum
Dec 2019
520.24M
Average
540.89M
Median
Dec 2021
Shareholders Equity (Quarterly) Benchmarks
Tonix Pharmaceuticals Holding Corp | 105.52M |
Amylyx Pharmaceuticals Inc | 433.43M |
Regulus Therapeutics Inc | 21.19M |
Minerva Neurosciences Inc | -28.46M |
Viking Therapeutics Inc | 348.42M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 748.96M |
Total Liabilities (Quarterly) | 317.20M |
Current Ratio | 2.423 |